Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116

Chinese Journal of Digestive Diseases

Volumn 6, Issue 1, 2005, Pages 15-20

  Zou, Jian ^a   Ran, Zhi Hua ^a   Xu, Qi ^a   Xiao, Shu Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colon cancer; Enzyme linked immunosorbent assay; Oxymatrine; Polymerase chain reaction; Telomerase

Indexed keywords

MYC PROTEIN; OXYMATRINE; PROTEIN MAD1; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALKALOIDS; ANTIVIRAL AGENTS; CELL DEATH; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 16344395310     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2005.00181.x     Document Type: Article

References (16)

1. Chen XS, Wang GJ, Cai X et al. Inhibition of hepatitis B virus by oxymatrine in vivo. World J Gastroenterol 2001; 7: 49-52.
2. Liu J, Manheimer E, Tsutani K et al. Medicinal herbs for hepatitis C virus infection: a coherent hepatobiliary systematic review of randomized trials. Am J Gastroenterol 2003; 98: 538-44.
3. Liu M, Liu XY, Cheng JF. Advance in the pharmacological research on matrine. Chin J Chin Mater Med 2003; 28: 801-4 (in Chinese).
4. Zhang JP, Zhang M, Zhou JP et al. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin 2001; 22: 183-6.
5. Wang LQ, Yu SC, Li YQ. Study on the anti-neoplastic activity of matrine and hairy vein agrimonia herb with blood serum pharmacological method. Chin J Trad MedSci Technol 1995; 5: 19-21 (in Chinese).
6. Zhang LP, Jiang JK, Tam JW et al. Effects of matrine on proliferation and differentiation in K-562 cells. Leuk Res 2001; 9: 793-800.
7. Zhang YJ, Xia T, Zhao JB. Effects of matrine on induction and differentiation in SMMC-7721 cancer cell line. J Fourth Military Med Univ 1998; 3: 340-3.
8. He YJ, Jiang JK, Ou YH et al. Matrine affects early expression of proto-oncogenes in K562 cells. Chin J Cancer 2002; 4: 369-72 (in Chinese).
9. Liu BZ, Jiang JK, He YJ et al. Effects of matrine on the activity of protein tyrosine kinase and phosphatase in K562 cells. Chin J Cancer 2002; 12: 1292-5 (in Chinese).
10. Lin W, Zhang JP, Hu ZL et al. Inhibitory effect of matrine on lipopolysacchride-induced tumor necrosis factor and interleukin-6 production from rat Kupffer cells. Acta Pharm Sin 1997; 2: 93-6 (in Chinese).
11. Zhang L, Jiang J, Tan R. Effects of matrine on telomerase activity and cell cycle in K562 cell. Chin J Oncol 1998; 5: 328-9 (in Chinese).
12. Horikawa I, Cable PL, Afshari C et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999; 59: 826-30.
13. Takakura M, Kyo S, Kanaya T et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999; 59: 551-7.
14. Sangtack O, Young HS, Jeongbin Y et al. Indentification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 2000; 19: 1485-90.
15. Masahiro T, Takahiro T, Taro K et al. Sp 1 cooperates with c-myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucl Acids Res 2000; 3: 669-77.
16. Ducrest AL, Szutorisz H, Lingner J et al. Regulation of the human telomerase reverse transcriptase gene. Oncogene 2002; 21: 541-52.